HIMS Stock — Hims & Hers Health Inc.

Hims & Hers Health Inc. (HIMS)

HIMS is a Stock. Total return is 185.6% over the past 7 years, 4.7 points ahead of SPY at 180.9%.

Hims & Hers Health operates a consumer-focused telehealth platform that connects patients with licensed healthcare professionals across the United States and multiple international markets, offering prescription medications, over-the-counter products, cosmetics, supplements, and laboratory testing services through its website and mobile app. The company focuses on areas including sexual health, hair care, skincare, weight loss, mental health, and chronic condition management. As an operating company, Hims & Hers does not currently have a stated distribution rate or regular dividend payments.

HIMS performance versus SPY

Price and return data through 2026-09-18.

Total return is 185.6% over the past 7 years, 4.7 points ahead of SPY at 180.9%. Over the past year its total return — price change plus distributions reinvested — is -50.2%. Its deepest 1-year drawdown was 76.9%.

HIMS key facts

Asset type

Stock

Asset class

Equity

Inception date

09/13/2019

Distribution frequency

None

Last close

$27.99 (as of 2026-09-18)

Market cap

$6,295,952,762

Average volume

9374100.0

Beta

2.412

Payout ratio

0.0

P/E ratio

57.1373

Forward P/E

72.4638

EPS

$-0.64

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

HIMS risks and drawbacks

The deepest 1-year drawdown on record here is 76.9%.

Who may consider HIMS — and who may not

It is a weaker fit for investors who need monthly cash flow (HIMS does not currently distribute); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

Compare HIMS

HIMS vs similar funds:

• HIMS vs HMYY

Frequently asked questions